Preclinical evaluation of a 64Cu-labeled αvβ6-targeting peptide PET probe for pancreatic cancer: from radiometal production to molecular probe validation

Key Points

• The 64Cu-labeled αvβ6-targeting peptide PET probe effectively targets pancreatic cancer.
• In vitro and in vivo studies demonstrate high specificity with a significant uptake in pancreatic tumor tissues.
• This study utilizes advanced radiometal production techniques for the probe synthesis and validation.
• These findings suggest a promising new tool for early diagnosis of pancreatic cancer, though clinical trials are needed.